PTC Therapeutics | PTCT - Les Intérêts Débiteurs Sur La Dette





Les Intérêts Débiteurs Sur La Dette Changement Date
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Alnylam Pharmaceuticals USD -84.37M 166.42M 2026-09
Amgen USD 653M 94.99B 2026-09
BioCryst Pharmaceuticals USD 21.71M 7.58M 2026-06
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 55.63M 7.67M 2026-09
Cytokinetics USD 38.48M 3.65M 2026-09
Daiichi Sankyo JPY 14.13B 10.56B 2026-09
Enanta Pharmaceuticals USD 1.96M 620K 2024-12
Gilead Sciences USD 269M 22M 2026-09
Incyte USD 605K 23K 2026-09
Ionis Pharmaceuticals USD 18M 1000K 2026-06
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
Karyopharm Therapeutics USD 12.55M 66K 2026-03
Novartis USD 468M 6M 2026-09
Pfizer USD 662M 5M 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Puma Biotechnology USD 3.37M 11K 2024-06
Roche Holding CHF 304M 7.5M 2025-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 21.51M 205K 2026-06
TG Therapeutics USD 16.57M 8.91M 2026-06
Ultragenyx Pharmaceutical USD 20M 2M 2026-09
Vertex Pharmaceuticals USD 36M 32.7M 2026-09
Xencor USD 4.11M 3.24M 2026-09